What is Alpha Cognition's CN — revenue?

Alpha Cognition (ACOG) reported CN — revenue of $29.98K in Q1 2026.

What does CN — revenue mean?

This metric represents the total gross income generated by the company's specific geographic or operational segment. It reflects the market adoption and commercial success of the company's therapeutic offerings within this defined region. Monitoring this figure helps investors assess the segment's contribution to the company's overall top-line growth and commercialization progress.

Alpha Cognition ACOG CN — Revenue

Other geography segments

$3.5M+910%

Similar metrics at other companies

NUVBCN — Revenue

$5.19M+78.8%

XPERCN — Revenue

$9.77M-34.2%

CBTCN — Revenue

$232.75M-5.3%

AMP

AMPHCN — Revenue

$2.48M+2,964%

NTICCN — Revenue

$4.43M+18.5%

FBINCN — Revenue

$36.8M-37.0%

Other financials

Income statement

See full

Revenue$3.5M+20.7%

Gross profit$3.3M+12.7%

Operating income-$8.1M-138%

Net income-$6.5M-276%

EPS (diluted)-$0.32-191%

Balance sheet

See full

Cash & equivalents$54.3M+100,638%

Total equity$57.5M+49.2%

Total assets$69.2M+42.5%

Cash flow

See full

Operating cash flow-$11.8M-477%

CapEx$1.3K-97.9%

Free cash flow-$11.8M-460%

Valuation

See full

Market cap$157.21M+6.6%

P/S14.5×—

Profitability

See full

Gross margin89.3%—

Operating margin-250.1%—

Net margin-232.2%—

FCF margin-280.5%—

Returns & leverage

See full

Return on equity-52.4%-5.3pp

Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's cn — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alpha Cognition's CN — revenue?: Alpha Cognition (ACOG) reported CN — revenue of $29.98K in Q1 2026.
What does CN — revenue mean?: This metric represents the total gross income generated by the company's specific geographic or operational segment. It reflects the market adoption and commercial success of the company's therapeutic offerings within this defined region. Monitoring this figure helps investors assess the segment's contribution to the company's overall top-line growth and commercialization progress.